Hcrn Bre 19-433: A Multi-Institutional Phase Ii Study To Evaluate Efficacy And Safety Of Talazoparib, Radiotherapy And Atezolizumab In Gbrca 1/2 Negative Patients With Pd-L1+ Metastatic Triple Negative Breast Cancer (Tara)
Atezolizumab;Talazoparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Hcrn Bre 19-433: A Multi-Institutional Phase Ii Study To Evaluate Efficacy And Safety Of Talazoparib, Radiotherapy And Atezolizumab In Gbrca 1/2 Negative Patients With Pd-L1+ Metastatic Triple Negative Breast Cancer (Tara) ### Output: Atezolizumab;Talazoparib